MIR128-1 Gene

HGNC Family Non-coding RNAs
Name microRNA 128-1
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMIR128‐1 plays a critical role in the central nervous system where it fine‐tunes gene expression to support normal neuronal development and function. In primary neurons, MIR128‐1 is deregulated by viral proteins such as HIV‐Tat, leading to downregulation of key synaptic proteins (e.g. SNAP25) that control neurotransmission and synaptic integrity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In differentiating neural cells, including models of neuroblastoma, MIR128‐1 is up‐regulated and acts to suppress pro‐migratory proteins such as Reelin and DCX, thereby reducing aberrant migration and invasiveness."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Furthermore, in the brain MIR128‐1 represses the nonsense-mediated decay machinery by targeting key components (UPF1 and MLN51), a mechanism that is conserved during brain development, while its dysregulation has also been implicated in Alzheimer’s disease through impaired lysosomal function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn cancer cells, MIR128‐1 exerts tumor‐suppressive functions by modulating multiple signaling pathways that control cell proliferation, apoptosis, migration, and epithelial–mesenchymal transition (EMT). In prostate, pituitary, and esophageal cancers, for example, up‐regulation of MIR128‐1 diminishes invasive behavior via direct targeting of regulators such as FADD (thereby altering Fas‐mediated apoptosis), BMI1, and ZEB1."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "10"}]}, {"type": "t", "text": " In glioblastoma and ovarian carcinoma models, enforced MIR128‐1 expression limits cell growth and invasion by targeting oncogenic mediators such as Rap1B, as well as by interfering with PI3K/AKT signaling via regulators like PIK3R1; similar roles have been reported in hepatocellular carcinoma and colorectal cancer where MIR128‐1 represses key drivers (e.g. NEK2, ITGA2, Galectin‐3) that otherwise promote tumor progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "18"}]}, {"type": "t", "text": " Additional studies in glioblastoma, thyroid, and breast cancer further demonstrate that MIR128‐1 downregulates oncogenic transcription factors and cell cycle regulators (e.g. via BMI1, E2F3, and NEK2 inhibition) to diminish tumor cell aggressiveness."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "19", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its intrinsic tumor‐suppressive functions, MIR128‐1 modulates chemoresistance across several cancer types. In hormone‐dependent breast cancer, its hormone‐responsive upregulation in aromatase inhibitor–resistant cells perturbs TGFβ signaling, whereas in glioblastoma, MIR128‐1 upregulation by temozolomide promotes cytotoxicity by inhibiting mTOR signaling and c‐Met–mediated EMT."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": " Moreover, in bladder and ovarian cancers, ceRNA networks involving long noncoding RNAs (e.g. PVT1 and linc00161) sequester MIR128‐1 to relieve repression of pro‐tumorigenic targets (such as VEGFC and MAPK1), thereby contributing to drug resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenesis, MIR128‐1 also contributes to non‐neoplastic and metabolic regulation. Genetic polymorphisms in its locus have been associated with susceptibility to diabetic neuropathies, suggesting roles in neuronal and vascular function. In non‐cancerous models, MIR128‐1 preserves genomic stability by directly repressing LINE‐1 retrotransposon mobilization, thereby reducing mutagenic potential."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": " Furthermore, in the vascular endothelium, MIR128‐1 modulates shear stress–dependent responses by targeting regulators (e.g. KLF4) that influence inflammation and angiogenesis, and in metabolic disease models, its activity is linked to energy‐storage phenotypes that may have conferred an evolutionary “thrifty” advantage."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "30", "end_ref": "32"}]}, {"type": "t", "text": " Additionally, associations with diabetic neuropathy further underscore its importance in peripheral nerve regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Davide Eletto, Giuseppe Russo, Giovanni Passiatore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.21452"}], "href": "https://doi.org/10.1002/jcp.21452"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18381601"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18381601"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jie Shen, Christine B Ambrosone, Hua Zhao "}, {"type": "b", "children": [{"type": "t", "text": "Novel genetic variants in microRNA genes and familial breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.24008"}], "href": "https://doi.org/10.1002/ijc.24008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19048628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19048628"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Cristina Evangelisti, Maria Carolina Florian, Isabella Massimi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.09-134965"}], "href": "https://doi.org/10.1096/fj.09-134965"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19713529"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19713529"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ivone G Bruno, Rachid Karam, Lulu Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2011.04.018"}], "href": "https://doi.org/10.1016/j.molcel.2011.04.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21596314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21596314"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Roberto Tiribuzi, Lucia Crispoltoni, Serena Porcellati, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2013.08.003"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2013.08.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24064186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24064186"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Amjad P Khan, Laila M Poisson, Vadiraja B Bhat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Proteomics (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/mcp.M900159-MCP200"}], "href": "https://doi.org/10.1074/mcp.M900159-MCP200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19955085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19955085"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Selma Masri, Zheng Liu, Sheryl Phung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-009-0716-3"}], "href": "https://doi.org/10.1007/s10549-009-0716-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20054641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20054641"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "T Palumbo, F R Faucz, M Azevedo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.190"}], "href": "https://doi.org/10.1038/onc.2012.190"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22614013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22614013"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Y K Adlakha, N Saini "}, {"type": "b", "children": [{"type": "t", "text": "miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2013.46"}], "href": "https://doi.org/10.1038/cddis.2013.46"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23492773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23492773"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Nami Yamada, Shunsuke Noguchi, Minami Kumazaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of microRNA-128a expression contributes to the apoptosis-resistance of human T-cell leukaemia jurkat cells by modulating expression of fas-associated protein with death domain (FADD)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamcr.2013.11.022"}], "href": "https://doi.org/10.1016/j.bbamcr.2013.11.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24316133"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24316133"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Xiaoling She, Zhibin Yu, Yulong Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2014.3318"}], "href": "https://doi.org/10.3892/or.2014.3318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25017996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25017996"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Bing Li, Hong Chen, Nan Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deregulation of miR-128 in ovarian cancer promotes cisplatin resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gynecol Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/IGC.0000000000000252"}], "href": "https://doi.org/10.1097/IGC.0000000000000252"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25248111"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25248111"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Dianke Yu, Bridgett Green, April Marrone, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep08534"}], "href": "https://doi.org/10.1038/srep08534"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25704921"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25704921"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Belinda Hauser, Yuan Zhao, Xiaowu Pang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0116321"}], "href": "https://doi.org/10.1371/journal.pone.0116321"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25764126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25764126"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xianglun Sun, Youkong Li, Jie Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Jpn J Clin Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jjco/hyv027"}], "href": "https://doi.org/10.1093/jjco/hyv027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25921099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25921099"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Chao-Yuan Huang, Xin-Ping Huang, Ji-Ye Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.3936"}], "href": "https://doi.org/10.3892/or.2015.3936"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25962360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25962360"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Xinsheng Liu, Zhiyong Liang, Kehai Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin α2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4696-0"}], "href": "https://doi.org/10.1007/s13277-015-4696-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26700675"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26700675"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Dongmei Xiong, Yanrui Sheng, Shijia Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.10250"}], "href": "https://doi.org/10.18632/oncotarget.10250"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27351280"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27351280"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Zheng-Nan Shan, Rui Tian, Min Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.12385"}], "href": "https://doi.org/10.18632/oncotarget.12385"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27705931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27705931"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Weiqun Lu, Jia Wang, Guohua Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.14839"}], "href": "https://doi.org/10.18632/oncotarget.14839"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28146425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28146425"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Lili Zhao, Rui Li, Shanling Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Biochim Biophys Sin (Shanghai) (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/abbs/gmx132"}], "href": "https://doi.org/10.1093/abbs/gmx132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29329360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29329360"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Jing Chen, Dongjing Zhao, Qiang Meng "}, {"type": "b", "children": [{"type": "t", "text": "Knockdown of HCP5 exerts tumor-suppressive functions by up-regulating tumor suppressor miR-128-3p in anaplastic thyroid cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.108966"}], "href": "https://doi.org/10.1016/j.biopha.2019.108966"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31102936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31102936"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yinmou Guo, Peiru Yue, Yumei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109255"}], "href": "https://doi.org/10.1016/j.biopha.2019.109255"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31352238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31352238"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Chengbin Zhao, Ruiming Guo, Fangxia Guan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-020-65331-3"}], "href": "https://doi.org/10.1038/s41598-020-65331-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32528036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32528036"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yuanwen Chen, Nian Wu, Lei Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15317"}], "href": "https://doi.org/10.1111/jcmm.15317"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32558224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32558224"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Peng-Hsu Chen, Chia-Hsiung Cheng, Chwen-Ming Shih, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0167096"}], "href": "https://doi.org/10.1371/journal.pone.0167096"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27893811"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27893811"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Feng He, Zhi Song, Huacui Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-018-0432-8"}], "href": "https://doi.org/10.1038/s41388-018-0432-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30076414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30076414"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Mei Xu, Kai Zhou, Yuanzhe Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22952"}], "href": "https://doi.org/10.1002/mc.22952"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30556928"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30556928"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Matthias Hamdorf, Adam Idica, Dimitrios G Zisoulis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-128 represses L1 retrotransposition by binding directly to L1 RNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.3090"}], "href": "https://doi.org/10.1038/nsmb.3090"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26367248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26367248"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Hai-Ting Liu, Ai-Yan Xing, Xu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6059"}], "href": "https://doi.org/10.18632/oncotarget.6059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26460960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26460960"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Gui-Chun Ding, Min Chen, Yi-Xiong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-128a-induced apoptosis in HTR-8/SVneo trophoblast cells contributes to pre-eclampsia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.03.040"}], "href": "https://doi.org/10.1016/j.biopha.2016.03.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27261578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27261578"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Lifeng Wang, Nasa Sinnott-Armstrong, Alexandre Wagschal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A MicroRNA Linking Human Positive Selection and Metabolic Disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2020.09.017"}], "href": "https://doi.org/10.1016/j.cell.2020.09.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33058756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33058756"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Cinzia Ciccacci, Roberto Morganti, Davide Di Fusco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Diabetol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00592-014-0582-2"}], "href": "https://doi.org/10.1007/s00592-014-0582-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24682535"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24682535"}]}]}]}
Synonyms MIRN128A, MIR-128-1, MIRN128-1, MIR128A
NCBI Gene ID 406915
API
Download Associations
Predicted Functions View MIR128-1's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR128-1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR128-1's ARCHS4 Predicted Functions.

Functional Associations

MIR128-1 has 508 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 19 datasets.

Click the + buttons to view associations for MIR128-1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR128-1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR128-1 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR128-1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR128-1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR128-1 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR128-1 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR128-1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR128-1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GAD Gene-Disease Associations diseases associated with MIR128-1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR128-1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR128-1 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR128-1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR128-1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR128-1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR128-1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR128-1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by MIR128-1 gene mutations from the MPO Gene-Phenotype Associations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR128-1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR128-1 protein from the Wikipathways Pathways 2014 dataset.